Lemonade, Inc. $LMND Shares Sold by Baillie Gifford & Co.

Baillie Gifford & Co. decreased its holdings in shares of Lemonade, Inc. (NYSE:LMNDFree Report) by 5.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,942,056 shares of the company’s stock after selling 168,226 shares during the period. Baillie Gifford & Co.’s holdings in Lemonade were worth $157,488,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of LMND. Bayforest Capital Ltd purchased a new position in Lemonade in the 3rd quarter worth about $25,000. NewEdge Advisors LLC acquired a new position in Lemonade in the 1st quarter valued at approximately $35,000. Estabrook Capital Management purchased a new stake in shares of Lemonade during the second quarter worth $44,000. Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Lemonade by 30.7% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,034 shares of the company’s stock worth $45,000 after purchasing an additional 243 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its position in Lemonade by 1,733.3% during the second quarter. Golden State Wealth Management LLC now owns 1,100 shares of the company’s stock valued at $48,000 after acquiring an additional 1,040 shares in the last quarter. 80.30% of the stock is owned by institutional investors.

Lemonade Stock Down 3.6%

Shares of LMND stock opened at $93.10 on Friday. Lemonade, Inc. has a 12 month low of $24.31 and a 12 month high of $99.90. The stock has a 50-day moving average price of $77.82 and a 200 day moving average price of $61.44. The firm has a market cap of $6.96 billion, a price-to-earnings ratio of -38.95 and a beta of 1.98.

Lemonade (NYSE:LMNDGet Free Report) last announced its quarterly earnings data on Wednesday, November 5th. The company reported ($0.51) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.21. The business had revenue of $194.50 million for the quarter, compared to analyst estimates of $185.06 million. Lemonade had a negative net margin of 26.39% and a negative return on equity of 31.86%. Lemonade’s revenue was up 42.4% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.95) earnings per share. Sell-side analysts predict that Lemonade, Inc. will post -3.03 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Adina Eckstein sold 7,919 shares of the firm’s stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of $81.15, for a total transaction of $642,626.85. Following the sale, the chief operating officer owned 188,391 shares of the company’s stock, valued at approximately $15,287,929.65. This trade represents a 4.03% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider John Sheldon Peters sold 9,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $90.00, for a total transaction of $810,000.00. Following the sale, the insider owned 70,228 shares in the company, valued at $6,320,520. This trade represents a 11.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 306,350 shares of company stock valued at $25,870,918. Insiders own 14.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Citizens Jmp boosted their price target on Lemonade from $60.00 to $80.00 and gave the stock a “market outperform” rating in a research report on Monday, November 24th. Morgan Stanley set a $85.00 target price on shares of Lemonade and gave the company an “equal weight” rating in a research note on Tuesday, December 16th. Truist Financial started coverage on shares of Lemonade in a research note on Tuesday, January 6th. They set a “buy” rating and a $98.00 price target on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Lemonade in a research note on Wednesday, October 8th. Finally, Citigroup reaffirmed an “outperform” rating on shares of Lemonade in a report on Friday, January 16th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $71.50.

Read Our Latest Research Report on Lemonade

Trending Headlines about Lemonade

Here are the key news stories impacting Lemonade this week:

  • Positive Sentiment: Strategic Tesla partnership — Lemonade announced a technical collaboration to price miles driven under Tesla FSD with a ~50% discount, which investors view as validation of Lemonade’s data-driven pricing and a potential path to profitable customer acquisition. Lemonade’s Tesla Deal Could Rewrite How Auto Insurance Is Priced
  • Positive Sentiment: Product rollout & market reaction — Multiple press pieces highlight Lemonade’s new autonomous‑vehicle insurance for Tesla FSD users and the stock recently hit a multi‑year/52‑week high as investors priced in growth and margin upside from cross‑selling and lower acquisition costs. Insurtech Lemonade Unveils AI‑Driven Insurance for Autonomous Vehicles
  • Positive Sentiment: Unusual bullish options flow — Traders bought a material number of call contracts (notable increase vs. average), signalling speculative bullish interest that can amplify moves if the partnership narrative continues to play out.
  • Neutral Sentiment: Analyst attention & target resets — Coverage is being refreshed after the Tesla announcement; some analysts are raising targets while others caution gains may be short‑lived unless fundamentals keep improving. How Lemonade Is Rewriting Its Story As Analyst Targets Reset
  • Neutral Sentiment: Zacks note on sustainability of the jump — Zacks flagged that heavy volume and estimate revisions drove the recent ~13% jump but warned that the momentum may not immediately extend without follow‑through on estimates. Strength Seen in Lemonade: Can Its 13.1% Jump Turn into More Strength?
  • Negative Sentiment: Large insider sales — CEO Daniel Schreiber sold 126,625 shares (~$12.0M at ~$94.74) and another insider (John Sheldon Peters) sold 9,000 shares (~$810k). These sizable, disclosed Form 4 sales can be interpreted as near‑term supply pressure or signal for some investors to take profits. Schreiber SEC Form 4 Peters SEC Form 4
  • Negative Sentiment: Execution & regulatory risk — The Tesla product rollout is currently limited and depends on FSD safety metrics and state/regulatory approvals; any setbacks or higher claims could hurt Lemonade’s improved margin story (this is noted in coverage of the deal).

Lemonade Profile

(Free Report)

Lemonade, Inc (NYSE: LMND) is a New York–based technology-driven insurance carrier that leverages artificial intelligence and behavioral economics to streamline the purchase and management of policies. Founded in 2015, the company offers renters, homeowners, pet, term life and car insurance products tailored for digitally savvy consumers. By automating underwriting and claims processing through chatbots and machine learning, Lemonade aims to deliver a more transparent and user-friendly experience than traditional insurers.

The company’s product suite includes standalone policies for renters and homeowners, customizable pet insurance plans, and term life coverage with simple online applications.

Further Reading

Want to see what other hedge funds are holding LMND? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lemonade, Inc. (NYSE:LMNDFree Report).

Institutional Ownership by Quarter for Lemonade (NYSE:LMND)

Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.